Cold Spring Harbor, NY — Dr. Lars Zender, a senior clinical postdoctoral fellow at 黑料吃瓜资源 (CSHL) was recently awarded a $40,000 grant for his seminal contributions in the field of cancer biology and epigenomics. The grant, presented at the second annual 鈥淐racking the Code with the Bear鈥� Research Symposium, will fund Zender鈥檚 ongoing cancer research.
鈥淟ars has done an outstanding job integrating work with mouse cancer models, cancer genomics, and RNA interference to identify genes that contribute to human cancer,鈥� said Scott Lowe, Ph.D., deputy director of the CSHL Cancer Center and Howard Hughes Medical Institute investigator. 鈥淗is approach shifts the paradigm. The genes he has identified suggest new approaches for treating cancer. This award is a wonderful recognition of both his current impact and future potential.鈥�
The symposium, sponsored by the Bear Necessities Pediatric Cancer Foundation in Chicago, IL, provides a forum for ten exceptional post-doctoral scientists from prominent institutions in the US and Canada to present their current cancer research. The Bear Foundation selected the presenters based on nominations received from mentors and senior leaders in their field of research. In addition to Zender, two other CSHL postdoctoral fellows presented their research. Dr. Danielle Irvine spoke about her work on the role of RNAi-mediated epigenetic genome regulation, and Dr. Julius Brennecke presented his work on piRNAs in the Drosophila germline.
鈥淭o have three of the ten qualifying participants at the symposium representing 黑料吃瓜资源 is impressive,鈥� David L. Spector, Ph.D., CSHL research director said. 鈥淐SHL鈥檚 groundbreaking research is largely due to our ability to attract and nurture the best young scientific minds.鈥�
鈥淐SHL is probably the most interactive institution that I know. In my project I was able to combine different state of the art technologies, taking our research to a new level,鈥� Zender said. 鈥淭he combination of 鈥榗utting edge鈥� technologies from different CSHL labs allowed me to address complex biological questions in a highly efficient and effective way.鈥� Zender鈥檚 research was made possible by multidisciplinary collaboration across several CSHL laboratories. Zender leveraged ROMA, a high-resolution genome scanning technology pioneered by CSHL to identify and validate two new oncogenes genes for liver cancer.
With the grant, Dr. Zender will be able to continue his project on 鈥渋n vivo RNAi screening鈥� to identify new tumor suppressor genes in liver cancer. In particular, the grant will enable the project to be conducted with the use of even more powerful next-generation sequencing technologies.
Written by: Communications Department | [email protected] | 516-367-8455
About Bear Necessities Pediatric Cancer Foundation
is a national organization whose mission is to eliminate pediatric cancer and to provide hope and support to those who are touched by it.